Phocas Financial Corp’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-293,538
| Closed | -$1.25M | – | 176 |
|
|
2023
Q2 | $1.25M | Buy |
293,538
+130,398
| +80% | +$557K | 0.17% | 128 |
|
|
2023
Q1 | $1.12M | Buy |
+163,140
| New | +$1.12M | 0.16% | 129 |
|
|
2022
Q3 | – | Sell |
-316,455
| Closed | -$2.29M | – | 203 |
|
|
2022
Q2 | $2.29M | Sell |
316,455
-67,555
| -18% | -$489K | 0.34% | 113 |
|
|
2022
Q1 | $4.96M | Sell |
384,010
-130,428
| -25% | -$1.68M | 0.62% | 71 |
|
|
2021
Q4 | $8.21M | Buy |
514,438
+9,502
| +2% | +$152K | 1.05% | 33 |
|
|
2021
Q3 | $8.11M | Buy |
504,936
+253,578
| +101% | +$4.07M | 1.03% | 29 |
|
|
2021
Q2 | $3.48M | Buy |
251,358
+49,730
| +25% | +$688K | 0.44% | 92 |
|
|
2021
Q1 | $2.95M | Buy |
201,628
+99,013
| +96% | +$1.45M | 0.39% | 103 |
|
|
2020
Q4 | $1.78M | Sell |
102,615
-20,847
| -17% | -$362K | 0.27% | 114 |
|
|
2020
Q3 | $2.26M | Buy |
123,462
+3,946
| +3% | +$72.4K | 0.39% | 108 |
|
|
2020
Q2 | $2.13M | Sell |
119,516
-10,343
| -8% | -$185K | 0.38% | 113 |
|
|
2020
Q1 | $2.11M | Buy |
129,859
+16,311
| +14% | +$265K | 0.42% | 101 |
|
|
2019
Q4 | $2.04M | Buy |
+113,548
| New | +$2.04M | 0.25% | 117 |
|